Enzo Biochem, a biotechnology company renowned for producing and distributing DNA-based tests designed to identify viral and bacterial diseases, has recently confirmed in a filing with the Securities and Exchange Commission (SEC) that it fell victim to a ransomware attack.
The malicious cyber assault has exposed the confidential information of 2.47 million patients, including names, test information and 600,000 Social Security numbers.